These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24055605)

  • 1. The interferon-inducible MxB protein inhibits HIV-1 infection.
    Liu Z; Pan Q; Ding S; Qian J; Xu F; Zhou J; Cen S; Guo F; Liang C
    Cell Host Microbe; 2013 Oct; 14(4):398-410. PubMed ID: 24055605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB.
    Liu Z; Pan Q; Liang Z; Qiao W; Cen S; Liang C
    Retrovirology; 2015 Jan; 12():1. PubMed ID: 25571928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamins are forever: MxB inhibits HIV-1.
    Haller O
    Cell Host Microbe; 2013 Oct; 14(4):371-3. PubMed ID: 24139395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human MxB Inhibits the Replication of Hepatitis C Virus.
    Yi DR; An N; Liu ZL; Xu FW; Raniga K; Li QJ; Zhou R; Wang J; Zhang YX; Zhou JM; Zhang LL; An J; Qin CF; Guo F; Li XY; Liang C; Cen S
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host and viral determinants for MxB restriction of HIV-1 infection.
    Matreyek KA; Wang W; Serrao E; Singh PK; Levin HL; Engelman A
    Retrovirology; 2014 Oct; 11():90. PubMed ID: 25348155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
    Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
    Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection.
    Xu B; Pan Q; Liang C
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
    Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
    Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
    J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.
    Buffone C; Schulte B; Opp S; Diaz-Griffero F
    J Virol; 2015 Mar; 89(6):3285-94. PubMed ID: 25568212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insight into HIV-1 restriction by MxB.
    Fribourgh JL; Nguyen HC; Matreyek KA; Alvarez FJD; Summers BJ; Dewdney TG; Aiken C; Zhang P; Engelman A; Xiong Y
    Cell Host Microbe; 2014 Nov; 16(5):627-638. PubMed ID: 25312384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.
    Staeheli P; Haller O
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
    Steiner F; Pavlovic J
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MXB inhibits murine cytomegalovirus.
    Jaguva Vasudevan AA; Bähr A; Grothmann R; Singer A; Häussinger D; Zimmermann A; Münk C
    Virology; 2018 Sep; 522():158-167. PubMed ID: 30032029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
    Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
    J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M
    PLoS Pathog; 2024 Mar; 20(3):e1011830. PubMed ID: 38512975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
    Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
    J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.
    De Iaco A; Luban J
    Retrovirology; 2014 Jan; 11():11. PubMed ID: 24479545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1.
    Fricke T; White TE; Schulte B; de Souza Aranha Vieira DA; Dharan A; Campbell EM; Brandariz-Nuñez A; Diaz-Griffero F
    Retrovirology; 2014 Aug; 11():68. PubMed ID: 25123063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 resists MxB inhibition of viral Rev protein.
    Wang Z; Chai K; Liu Q; Yi DR; Pan Q; Huang Y; Tan J; Qiao W; Guo F; Cen S; Liang C
    Emerg Microbes Infect; 2020 Dec; 9(1):2030-2045. PubMed ID: 32873191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.